)
Our clients' news
Alize RP is a partner of HTID® – 24 & 25 June 2019
On June 24 and 25, 2019, the first edition of the HealthTech Investor Days (HTID®) will take place, organized by France Biotech. The event will bring together the most promising HealthTech companies (Biotech, Medtech, E-Health, Artificial Intelligence), major pharmaceutical groups and international investment funds. No less than 450 international actors will gather in Paris to […]
Say Hello to a New Biotech Striving to Prevent Kidney Damage During Surgery
Balmes Transplantation has raised €700,000 in seed funding to run a proof-of-concept study to test its drug combination for kidney damage. Balmes Transplantation is a young biotech in Marseille, France, that develops combination therapies for a common complication associated with kidney transplants and heart surgery. The biotech has raised a €700,000 seed funding from top company executives and angel […]
Deinove and Hallstar team up to create new bacterial extract ingredient
Deinove has partnered with Hallstar’s Oléos to create a new active ingredient for use in skin care products Pour accéder à l’article, veuillez cliquer sur le lien ci-dessous : https://www.cosmeticsbusiness.com/news/article_page/Deinove_and_Oleos_team_up_to_create_new_bacterial_extract_ingredient/139182
Sensorion Announces Multiple Poster Presentations at the ARO 2018 MidWinter Meeting
Company’s Potential Treatments and Screening Approaches for Inner Ear Disorders Prominently Highlighted Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, today announces that it will present five posters at the Association for Research in Otolaryngology’s (ARO) 41st Annual MidWinter Meeting in San Diego, California, which takes place from […]
VALBIOTIS announces a significant effect of VALEDIA® on intestinal microbiota
∙ VALEDIA® acts on microbiota imbalances associated with metabolic diseases (preclinical) ∙ In addition to the Phase I/II efficacy results in humans, this additional data strengthens the value of VALEDIA® for preventing type 2 diabetes ∙ VALBIOTIS continues its metagenomics program to assess how its products affect the microbiota VALBIOTIS (FR0013254851 – ALVAL / PEA/SME […]
Vexim: +17% growth in sales in 2017 up to €21.6 million
Strong International growth: +42% up to €2.4 million Continued growth in Europe: +14% up to €19.2 million More than 60,500 SpineJack® implants sold since 2011 VEXIM (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces its consolidated sales results for the full year 2017, as […]
Adocia announces expanded BioChaperone® product portfolio beyond diabetes
Following its successful application to diabetes treatments, BioChaperone® technology will now be deployed in a selected range of injectable therapeutics across numerous therapeutic areas Initial programs added to the portfolio include a ready-to-inject version of teduglutide for the treatment of short bowel syndrome and a fixed dose combination of glucagon and exenatide for the treatment […]